Tagged with diabetes

UAE The UAE’s rapid economic growth over the last half-century has been accompanied by a surge in lifestyle diseases such as diabetes and obesity. Both public and private organizations are now stepping up to tackle this health and economic burden with expanded access to cutting-edge treatments, a greater focus on education…

Thailand Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma multinationals in Thailand. Upon this solid foundation, Novo is now looking to bring the company’s latest and most innovative products to Thailand, branch out into obesity treatments, and…

Algeria Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management.   Noncommunicable diseases are a growing burden in Algeria. The results of a STEPwise survey revealed that, for adults aged between 18 and 69 years, 23.6…

Korea Industry players – from Big Pharma giants to small local startups – are bringing new, innovative solutions to market in Korea in order to try and solve the country’s diabetes epidemic.   The growing prevalence of Type 2 Diabetes is becoming a global issue. According to Dr Nam Han Cho,…

Taiwan Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to share his mission to fulfil CEO Lars Fruergaard Jørgensen’s strategy of expanding beyond being a leader of diabetes at the…

Puerto Rico After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli Lilly’s Puerto Rican affiliate last year. Among other things, he shares the reasons why Eli Lilly invests in strong commercial capabilities and clinical operations on the island,…

Canada Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via a ‘collective impact’ approach.   When I encountered the concept of collective impact in the Stanford Social Innovation Review, I realized the possibilities lay…

Thailand Dr Wannee Nitiyanant, president of the Diabetes Association of Thailand and Dr Supawadee Likitmaskul, president of the Siriraj Diabetes Center of Excellence, highlight the crucial importance of educate the public, patient and the healthcare professional in the diabetes field. They feature the priority of having more collaboration between the multi…

Thailand Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and Boehringer Ingelheim conducting more and more of their global trials in the country.   We are very active in engaging Thai doctors and patients in benefiting from involvement in…

Thailand Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In light of this epidemic, local diabetes associations and multinational pharma companies based in Thailand are coming together to provide awareness, education, and support to…

Thailand John Dawber, vice president and general manager of Novo Nordisk Thailand, offers his first impressions of the Thai market since moving from Japan. Dawber explains the current challenges and areas for improvement in diabetes treatment in Thailand, how the most innovative Novo Nordisk products have propelled the affiliate forward in…

Sweden Niels Abel Bonde, general manager of Novo Nordisk Sweden, explains the strategic significance of the Swedish market as an innovation-driven environment ideal to run pilot launches and real-world studies. He also breaks down the performance of the affiliate in its main therapeutic areas, as well as the positives and negatives…